Clinical trial
Improving Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (Vivitrol) Before vs. After Reentry
NCT02617628 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (Vivitrol) Before vs. After Reentry
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- December 31, 2018
- Enrollment
- 146 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opiate dependence